当前位置：
X-MOL 学术
›
Leuk. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry.
Leukemia Research ( IF 2.1 ) Pub Date : 2021-07-26 , DOI: 10.1016/j.leukres.2021.106673 Adriana Plesa 1 , Christophe Roumier 2 , Joris Gutrin 1 , Marie-Virginie Larcher 3 , Marie Balsat 3 , Octavia Cadassou 1 , Fiorenza Barraco 3 , Gaëlle Fossard 3 , Amandine Baudouin 4 , Hélène Labussière 3 , Isabelle Tigaud 1 , Sophie Ducastelle 3 , Sandrine Hayette 1 , Pierre Sujobert 1 , Maël Heiblig 3 , Mohamed Elhamri 3 , Xavier Thomas 3
中文翻译：
通过多参数流式细胞术评估 CPX-351 治疗的可测量残留疾病，包括 AML 白血病干细胞流。
更新日期：2021-07-26
Leukemia Research ( IF 2.1 ) Pub Date : 2021-07-26 , DOI: 10.1016/j.leukres.2021.106673 Adriana Plesa 1 , Christophe Roumier 2 , Joris Gutrin 1 , Marie-Virginie Larcher 3 , Marie Balsat 3 , Octavia Cadassou 1 , Fiorenza Barraco 3 , Gaëlle Fossard 3 , Amandine Baudouin 4 , Hélène Labussière 3 , Isabelle Tigaud 1 , Sophie Ducastelle 3 , Sandrine Hayette 1 , Pierre Sujobert 1 , Maël Heiblig 3 , Mohamed Elhamri 3 , Xavier Thomas 3
Affiliation
中文翻译：
通过多参数流式细胞术评估 CPX-351 治疗的可测量残留疾病，包括 AML 白血病干细胞流。
京公网安备 11010802027423号